We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Quantel Sa | LSE:0FRI | London | Ordinary Share | FR0000038242 | QUANTEL ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.48 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 207.89M | 7.13M | 0.3172 | 36.19 | 257.92M |
Lannion, December 14, 2023 – 5:45pm
LUMIBIRD ADJUSTS ITS 2023 GROWTH TARGET
The LUMIBIRD Group (FR0000038242 - LBIRD), the European leader for laser technologies, has reevaluated, a few weeks before its financial year-end, its revenue target for the current year. This has been adjusted to a minimum of €200m, with organic growth of at least 5%, lower than the 8% announced at the start of the year and confirmed at end-October.
The factors behind this adjustment, for the Medical and Photonics divisions, do not call into question the Group’s robust commercial development or its outlook for growth over the medium term. This primarily concerns:
The Medical division’s robust development is expected to be in line with the 8% announced.
For the Photonics division, the Defense and Space line of business is expected to exceed the 8% announced, while this growth will not offset the temporary contraction affecting the Industrial and Scientific and Lidar -lines of business. However, within the Lidar line of business, the Lidar Systems business will deliver a good performance.
The adjustment of the full-year revenues will mechanically have an impact on the EBITDA margin, which is expected to come in at over 17%, below the 20% announced1.
With strong demand in its growing markets, highlighted by a still very robust order book, Lumibird continues to be confident about its outlook for growth over the short and medium term. The Group has further strengthened its positions both technologically and industrially to continue building on its growth and ramping up its profitability over the coming years.
Next date: 2023 full-year revenues on January 29, 2024 (after close of trading)
LUMIBIRD is one of the world's leading specialists in lasers. With 50 years of experience and a mastering of solid state laser, laser diodes and fiber laser technologies, the Group designs, manufactures and markets high performance lasers for scientific (laboratories and universities), industrial (manufacturing, defense, Lidar sensors) and medical (ophthalmology, ultrasound diagnostic) markets.
Born from the combination of Keopsys Group with Quantel in October 2017, LUMIBIRD has more than 1 000 employees and over €191 million of consolidated revenues in 2022 and is present in Europe, America and Asia.
LUMIBIRD shares are listed on the Euronext Paris B Compartment. FR0000038242 – LBIRD www.lumibird.comSince 2022, LUMIBIRD is part of Euronext Tech Leaders
Contacts
LUMIBIRDMarc Le FlohicChairman and CEOTel. +33(0) 1 69 29 17 00info@lumibird.com | LUMIBIRDSonia RutnamChief Financial and Transformation OfficerTel. +33(0) 1 69 29 17 00info@lumibird.com | CalyptusMathieu CalleuxInvestors RelationsTel. +33(0) 1 53 65 37 91lumibird@calyptus.net |
1 Figures excluding Convergent Photonics, included in the Group’s basis for consolidation since August 31, 2023
Attachment
1 Year Quantel Chart |
1 Month Quantel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions